News | Radiation Dose Management | March 13, 2020

BIR Offers Guidance on Why Patient Contact Shielding is no Longer Needed

The guidance gives clarity and evidence to explain why the use of patient contact shielding to protect critical organs is no longer necessary for patients

The guidance gives clarity and evidence to explain why the use of patient contact shielding to protect critical organs is no longer necessary for patients

March 13, 2020 — The British Institute of Radiology (BIR) and a working party of U.K. radiological professional bodies and agencies have published evidence-based guidance that shows  patient contact shielding (such as aprons, thyroid or gonad shields) provides minimal or no benefit. It concludes that there are other areas of radiation protection which are more effective in optimizing radiation exposure such as education and training, good radiographic technique and use of technology.

When the use of protective aprons or shields for patients was first introduced, the imaging equipment gave out more radiation than machines today and it was thought that contact shielding could only provide a benefit to the patient.

In the past, a certain level of radiation dose was inevitable in order to get a good image, but technical advances in medical imaging equipment means that machines can now be adjusted to minimize radiation and still achieve a clear image for diagnosis. It has also become apparent that protective aprons or ‘contact shielding’ can sometimes cover up the part of the body which needs to be imaged, or the shielding can move during an examination or interfere with the imaging equipment. This might mean having a repeat X-ray, which could give additional radiation to the patient. This has led to inconsistencies in the use of contact shielding across the U.K..

Staff are well-trained in positioning the patient so that radiation to the body is minimised; ensuring that the patient is only exposed to enough radiation to achieve a good image.

They are also proficient in making the best use of technology to keep radiation dose as low as possible.

The evidence-based guidance was written by a collaborative working party including representatives from the British Institute of Radiology, Institute of Physics and Engineering in Medicine, Public Health England, the Royal College of Radiologists, Society and College of Radiographers and Society for Radiological Protection.

This guidance is about contact shielding for patients only. Staff working in the X-ray, CT room and in interventional radiology will still continue to wear aprons and shields because they are working in this area all the time and have greater exposure to radiation so they have the risk without the benefit. 

Peter Hiles, chair of the BIR working party said “This guidance offers clarity to both patients and professionals and hopefully will lead to a consistent approach in the future as this provides scientific evidence for change. However, it will require a major cultural change in outlook regarding radiation safety and practice in this area."

To read the guidance and for FAQs: www.bir.org.uk/patientshielding

Related Content

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve.

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve. Getty Images

Feature | Oncology Information Management Systems (OIMS) | May 27, 2020 | By Reshu Gupta
In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive.
Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
Off-site imaging companies are playing a key role in the fight against COVID-19
Feature | Coronavirus (COVID-19) | May 26, 2020 | By Sean Zahniser
After the worst of the COVID-19 pandemic has pas
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
A new technique developed by researchers at UC Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The team created a probe that generates two magnetic resonance signals that suppress each other until they reach the target, at which point they both increase contrast between the tumor and surrounding tissue

A new technique developed by researchers at UC Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The team created a probe that generates two magnetic resonance signals that suppress each other until they reach the target, at which point they both increase contrast between the tumor and surrounding tissue. Image courtesy of Xiandoing Xue, UC Davis

News | Magnetic Resonance Imaging (MRI) | May 26, 2020
May 26, 2020 — Researchers at the University of California, Davis offers a...
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).

Getty Images

News | Coronavirus (COVID-19) | May 21, 2020
May 21, 2020 — Despite facing challenges such as limited access to...
In response to the significant healthcare delivery changes brought on by COVID-19, Varian has launched new capabilities for its Noona software application, a powerful tool designed to engage cancer patients in their care for continuous reporting and symptom monitoring.
News | Radiation Oncology | May 21, 2020
May 21, 2020 — In response to the significant healthcare delivery changes brought on by...
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...